Cohere has acquired Reliant AI, a biopharma AI company with operations in Montreal and Berlin, to expand its sovereign enterprise AI platform. The acquisition integrates Reliant AI’s research team, proprietary biomedical datasets, and domain-optimized technology into Cohere’s platform, enhancing its capabilities in healthcare and life sciences. This move strengthens Cohere’s position as a global leader in sovereign AI, with a focus on security, data privacy, and regulatory compliance in highly regulated environments. According to Cohere’s Co-Founder and CEO, Aidan Gomez, the acquisition deepens the company’s work in healthcare and biopharma, where secure and domain-specific systems are critical. "Healthcare represents one of the most consequential opportunities for AI and it demands secure, sovereign, and domain-specific systems," Gomez said. "Together, we will accelerate progress in healthcare, building on our shared footprint across Canada and Germany to serve these critical sectors." Reliant AI’s flagship product is an intelligent research workbench used by global biopharma organizations to automate literature reviews, competitive landscaping, and extraction of unstructured scientific data. The platform also enables rapid identification of therapeutic precedents and modeling of market viability, accelerating decision-making and time to market. *Source: [cohere](https://cohere.com/blog/cohere-acquires-reliant-ai-expand-sovereign-enterprise-ai)*